Evidence map›Paper›PMID 41469064›Full record

ArticleBMJ open2025

Optimisation of oral anticoagulation for stroke prevention: a scoping review of factors influencing implementation.

Jo Catherine Weldon, Emma P Bray, Josephine Gibson, Munirah Bangee, Brigit Chesworth, Alison Doherty, Yasemin Hirst, Deirdre Lane, Cath Harris, Aasima Saeed Patel and 1 more

Abstract readScoping Review
In one paragraph

Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jo Catherine WeldonStroke Research Team, School of Nursing and Midwifery, University of Lancashire, Preston, UK.ORCID http://orcid.org/0000-0003-0729-8121
Emma P BrayStroke Research Team, School of Nursing and Midwifery, University of Lancashire, Preston, UK.ORCID http://orcid.org/0000-0001-9882-3539
Josephine GibsonStroke Research Team, School of Nursing and Midwifery, University of Lancashire, Preston, UK.ORCID http://orcid.org/0000-0002-3051-1237
Munirah BangeeStroke Research Team, School of Nursing and Midwifery, University of Lancashire, Preston, UK.
Brigit ChesworthStroke Research Team, School of Nursing and Midwifery, University of Lancashire, Preston, UK.
Alison DohertyApplied Health Research hub, University of Lancashire, Preston, UK.
Yasemin HirstApplied Health Research hub, University of Lancashire, Preston, UK.
Deirdre LaneUniversity of Liverpool, Liverpool, UK.ORCID http://orcid.org/0000-0002-5604-9378
Cath HarrisApplied Health Research hub, University of Lancashire, Preston, UK.
Aasima Saeed PatelApplied Health Research hub, University of Lancashire, Preston, UK.ORCID http://orcid.org/0009-0009-7491-6066
Caroline WatkinsStroke Research Team, School of Nursing and Midwifery, University of Lancashire, Preston, UK clwatkins@lancashire.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFor people whose stroke risk would be reduced by taking a long-term oral anticoagulant (OAC), it is important to implement effective strategies to support medication initiation, adherence and persistence. To do this, a better understanding of the factors associated with implementation of interventions to optimise OAC management is needed.

objectivesThis scoping review aimed to summarise the evidence-based characteristics associated with implementing interventions designed to optimise long-term OAC adherence. ELIGIBILITY CRITERIA: Primary research (published post-2000) evaluating any intervention designed to optimise implementation of long-term OAC for stroke prevention by way of change in OAC services, staff or patient behaviour. SOURCES OF EVIDENCE: Five databases (MEDLINE, Embase, Cumulative Index to Nursing and Allied Health Literature (CINAHL), PsycInfo, Cochrane Library) were searched from 1 January 2000 to 4 August 2023 using a combination of terms relating to population, intervention and study design. CHARTING

methodsTitles/abstracts were screened by at least one reviewer. Data from each full text were abstracted (with 20% double-checked for accuracy) and its implementation content reviewed, guided by the Expert Recommendations for Implementing Change strategies.

results216 studies were included, with varying descriptive reporting of implementation strategies, and only 61 (28%) self-identifying as an implementation study. The median number of implementation strategies used was three, with recently published studies (2015 onwards), those including patients receiving either direct OACs (DOACs) or vitamin K antagonists (VKAs) and those including multiple intervention targets (service, staff or patients) associated with using more implementation strategies. 'Train and educate stakeholders' strategies were the most commonly used, and 'Adapt and tailor to the context' strategies were the least used by included studies. Conversely, self-defined implementation studies were less likely to use 'Train and educate stakeholders' strategies, although they were positively associated with use of 'Adapt and tailor to the context'. 'Use evaluative & iterative' strategies were used more frequently in studies where patients used either VKAs or DOACs, or were published more recently.

conclusionsStudies need to self-define as implementation studies, improve implementation strategy reporting and be transparently registered, alongside conducting process evaluations or more richly describing implementation processes. Future research could explore why some implementation strategies are used more than others and whether aligning strategy clusters with intervention targets results in clinically significant differences in patient care.

Indexed as

AnticoagulantsStrokeAdministration, OralHumansMedication AdherenceAnticoagulantsImplementation SciencePREVENTIVE MEDICINEReviewSTROKE MEDICINE

Identifiers

PMID41469064
PMCPMC12750798

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.